XyloCor Therapeutics
Nikhil Thatte joined Lumira Ventures as a Principal in March 2019. He is responsible for investment sourcing and due diligence and is focused on next generation modalities including cell and gene therapy. Prior to Lumira Ventures, Mr. Thatte worked as a Director with DRI Capital, a pioneer in healthcare royalty monetization, and as a Consultant with ZS Associates, a global pharmaceutical consulting firm. He holds a Bachelor’s Degree in Chemical Engineering from McGill University.
This person is not in the org chart
This person is not in any offices
XyloCor Therapeutics
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.